Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for l‑Type Amino Acid Transporter 1‑Utilizing Prodrugs

• Published in: Molecular pharmaceutics 2023-02, Vol.20 (2), p.1331-1346
• Main Authors: Huttunen, Johanna, Kronenberger, Thales, Montaser, Ahmed B., Králová, Adéla, Terasaki, Tetsuya, Poso, Antti, Huttunen, Kristiina M.
• Format: Article
• Language: English
• Subjects: Amino Acid Transport Systems; Amino Acid Transport Systems, Neutral; Humans; MCF-7 Cells; Prodrugs - chemistry; Sodium
• ISSN: 1543-8384; 1543-8392
• DOI: 10.1021/acs.molpharmaceut.2c00948

Membrane transporters are the key determinants of the homeostasis of endogenous compounds in the cells and their exposure to drugs. However, the substrate specificities of distinct transporters can overlap. In the present study, the interactions of l-type amino acid transporter 1 (LAT1)-utilizing prodrugs with sodium-coupled neutral amino acid transporter 2 (SNAT2) were explored. The results showed that the cellular uptake of LAT1-utilizing prodrugs into a human breast cancer cell line, MCF-7 cells, was mediated via SNATs as the uptake was increased at higher pH (8.5), decreased in the absence of sodium, and inhibited in the presence of unselective SNAT-inhibitor, (α-(methylamino)­isobutyric acid, MeAIB). Moreover, docking the compounds to a SNAT2 homology model (inward-open conformation) and further molecular dynamics simulations and the subsequent trajectory and principal component analyses confirmed the chemical features supporting the interactions of the studied compounds with SNAT2, which was found to be the main SNAT expressed in MCF-7 cells.